Differences in SPET analysis of thyroid-associated orbitopathy [1]

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 5, 2004, Pages 793-795

  Galuska, Lázló ^a   Varga, József ^a   Szücs Farkas, Zsolt ^a   Nagy, Endre V ^a   Burman, Kenneth D ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTETATE TECHNETIUM TC 99M; SOMATOSTATIN RECEPTOR;

COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; LACRIMAL GLAND; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID GLAND;

EID: 2442476152     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1459-3     Document Type: Letter

References (8)

1. 99mTc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: the importance of the lacrimal gland. Eur J Nucl Med Mol Imaging 2003; 30:1155-1159.
2. 111In-octreotide. Thyroid 1997; 7:21-29.
3. 99mTc-depreotide SPET and MRI scores. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2.):S221.
4. Burggasser G, Hurtl I, Hauff W, Lukas J, Greifeneder M, Heydari B, Thaler A, Wedrich A, Virgolini I. Orbital scintigraphy with the somatostatin receptor tracer technetium-99m-P829 in patients with Graves' disease. Eur J Nucl Med Mol Imaging 2002; 29 (Suppl 1):331.
5. 99mTc-DTPA for the assessment of disease activity in Graves' ophthalmopathy: a comparison with the results from MR. Nucl Med Commun 2002; 23:1211-1216.
6. Konuk O, Atasever T, Unal M, Ayvaz G, Yetkin I, Akir N, Arslan M, Hasanreisoglu B. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy. Thyroid 2002; 12:603-608.
7. Ortapamuk H, Naldoken S, Hosal B. The role of Tc-99m polyclonal human immunoglobulin scintigraphy in Graves' ophthalmopathy. Eur J Nucl Med Mol Imaging 2002; 29 (Suppl 1): P595.
8. Szucs-Farkas Z, Tóth J, Balazs E, Galuska L, Burman KD, Karányi Z, Leovey A, Nagy VE. Using morphologic parameters of extraocular muscles for diagnosis and follow-up or Graves' ophthalmopathy: diameters, areas, or volumes? Am J Roentgenol 2002; 179:1-6.